Effect of aortic valve replacement on plasma soluble P-selectin, von Willebrand factor, and fibrinogen

被引:17
作者
Goldsmith, IRA
Blann, AD
Patel, RL
Lip, GYH
机构
[1] Univ Birmingham, Dept Med, City Hosp, Haemostasis Thrombosis & Vasc Biol Unit, Birmingham B18 7QH, W Midlands, England
[2] Walsgrave Gen Hosp, Dept Cardiothorac Surg, Coventry, W Midlands, England
关键词
D O I
10.1016/S0002-9149(00)01283-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We measured indexes of platelet activation (soluble P-selectin), endothelial dysfunction (von Willebrand factor), and fibrinogen in 54 patients who underwent aortic valve replacement (AVR): after mechanical AVR implantation, there was a significant increase in plasma levels of soluble P-selectin and von Willebrand factor levels 3 months after surgery, with no change in mean plasma fibrinogen levels. No significant changes in measured indexes were noted in patients undergoing biologic AVR, suggesting that mechanical AVR results in abnormal endothelial damage and/or dysfunction and platelet activation, which is not apparent among patients undergoing this procedure.
引用
收藏
页码:107 / +
页数:5
相关论文
共 11 条
  • [1] ALTMAN R, 1976, J THORAC CARDIOV SUR, V72, P127
  • [2] Hypothesis: Is soluble P-selectin a new marker of platelet activation?
    Blann, AD
    Lip, GYH
    [J]. ATHEROSCLEROSIS, 1997, 128 (02) : 135 - 138
  • [3] TRIAL OF COMBINED WARFARIN PLUS DIPYRIDAMOLE OR ASPIRIN THERAPY IN PROSTHETIC HEART-VALVE REPLACEMENT - DANGER OF ASPIRIN COMPARED WITH DIPYRIDAMOLE
    CHESEBRO, JH
    FUSTER, V
    ELVEBACK, LR
    MCGOON, DC
    PLUTH, JR
    PUGA, FJ
    WALLACE, RB
    DANIELSON, GK
    ORSZULAK, TA
    PIEHLER, JM
    SCHAFF, HV
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1983, 51 (09) : 1537 - 1541
  • [4] PREVENTION OF ARTERIAL THROMBOEMBOLISM WITH ACETYLSALICYLIC-ACID - CONTROLLED CLINICAL-STUDY IN PATIENTS WITH AORTIC BALL VALVES
    DALE, J
    MYHRE, E
    STORSTEIN, O
    STORMORKEN, H
    EFSKIND, L
    [J]. AMERICAN HEART JOURNAL, 1977, 94 (01) : 101 - 111
  • [5] Plasma fibrinogen, soluble P-selectin, and von Willebrand factor in aortic valve disease: evidence for abnormal haemorheology, platelet activation, and endothelial dysfunction
    Goldsmith, IRA
    Blann, AD
    Patel, RL
    Lip, GYH
    [J]. HEART, 2000, 83 (05) : 577 - 578
  • [6] KAWAZOE K, 1990, THROMB RES, P27
  • [7] von Willebrand factor: A marker of endothelial dysfunction in vascular disorders?
    Lip, GYH
    Blann, A
    [J]. CARDIOVASCULAR RESEARCH, 1997, 34 (02) : 255 - 265
  • [8] Thrombogenesis in mitral regurgitation and aortic stenosis
    Lip, GYH
    Rumley, A
    Dunn, FG
    Lowe, GDO
    [J]. ANGIOLOGY, 1996, 47 (12) : 1117 - 1125
  • [9] Rams J J, 1993, J Heart Valve Dis, V2, P37
  • [10] A COMPARISON OF ASPIRIN WITH PLACEBO IN PATIENTS TREATED WITH WARFARIN AFTER HEART-VALVE REPLACEMENT
    TURPIE, AGG
    GENT, M
    LAUPACIS, A
    LATOUR, Y
    GUNSTENSEN, J
    BASILE, F
    KLIMEK, M
    HIRSH, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (08) : 524 - 529